全文获取类型
收费全文 | 79168篇 |
免费 | 6560篇 |
国内免费 | 4927篇 |
专业分类
90655篇 |
出版年
2024年 | 141篇 |
2023年 | 907篇 |
2022年 | 2097篇 |
2021年 | 3627篇 |
2020年 | 2336篇 |
2019年 | 2849篇 |
2018年 | 2882篇 |
2017年 | 2041篇 |
2016年 | 2896篇 |
2015年 | 4603篇 |
2014年 | 5314篇 |
2013年 | 5987篇 |
2012年 | 6931篇 |
2011年 | 6373篇 |
2010年 | 3831篇 |
2009年 | 3390篇 |
2008年 | 4125篇 |
2007年 | 3667篇 |
2006年 | 3185篇 |
2005年 | 2700篇 |
2004年 | 2286篇 |
2003年 | 1980篇 |
2002年 | 1734篇 |
2001年 | 1560篇 |
2000年 | 1569篇 |
1999年 | 1455篇 |
1998年 | 851篇 |
1997年 | 800篇 |
1996年 | 809篇 |
1995年 | 737篇 |
1994年 | 692篇 |
1993年 | 534篇 |
1992年 | 822篇 |
1991年 | 658篇 |
1990年 | 601篇 |
1989年 | 531篇 |
1988年 | 422篇 |
1987年 | 362篇 |
1986年 | 337篇 |
1985年 | 300篇 |
1984年 | 221篇 |
1983年 | 199篇 |
1982年 | 112篇 |
1981年 | 118篇 |
1980年 | 86篇 |
1979年 | 147篇 |
1978年 | 84篇 |
1977年 | 95篇 |
1975年 | 111篇 |
1974年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
821.
Xiao-Chen Chen Hao Sun Chang-Jun Zhang Ying Zhang Ke-Qin Lin Liang Yu Lei Shi Yu-Fen Tao Xiao-Qin Huang Jia-You Chu Zhao-Qing Yang 《遗传学报》2013,40(10):543-548
The ataxin-2 (ATXN2) gene is located on human chromo-some 12q24.1. In normal individuals, the coding region in exon 1 of this gene has fewer than 31 CAG repeats (Yu et al., 2005: Laffita-Mesa et al., 2012). However, an abnormal expansion of CAG trinucleotide repeats results in the aggre-gation of polyglutamine (polyQ), which causes spinocer-ebellar ataxia type 2 (SCA2) (Pulst et al., 1996). The expanded alleles have more than 32 repeats in the affected individuals, and generally there is an inverse correlation between CAG repeat length and age of onset (Pulst et al., 1996). SCA2 is an autosomal dominant inheritance neurodegenerative disease, whose major clinical feature is progressive cerebellar ataxia. Atrophies of the brainstem and frontal lobe have been frequently detected by magnetic resonance imaging (MRI) (Yamamoto-Watanabe et al., 2010). This disease has the strong effect on sensory and motor control. 相似文献
822.
Nm23 is a family of genes encoding the nucleoside diphosphate (NDP) kinase, which functions in a wide variety of biological processes, including growth, development, differentiation and tumor metastasis. In this study, a novel nm23 gene, designated as Mrnm23, was identified from the freshwater giant prawn Macrobrachium rosenbergii. The full-length cDNA was 776 bp in length, encoding for a protein of 176 amino acids with one typical NDP kinase domain that harbored all the crucial residues for nucleotide binding and enzymatic activity. Like human novel nm23-H1B, the putative protein contained a unique 21-amino-acid NH2-terminal extension as compared to human nm23 (nm23-H1) homologs. Further, 3 extra amino acid residues prolonged the COOH-terminus. The Mrnm23 was ubiquitously expressed in all tissues examined, including androgenic gland, gill, heart, liver, muscle, ovary, and testis. In situ hybridization to gonad sections indicated that the Mrnm23 mRNA was localized in the cytoplasm of cup-base of differentiating spermatids, in the spike of the umbrella-shaped spermatozoa and in the cytoplasm of the early previtellogenic oocytes, suggesting that the Mrnm23 has potential roles in spermiogenesis and early differentiation of oocyte. 相似文献
823.
A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors
Yung-An Tsou Kuan-Chung Chen Su-Sen Chang Yeong-Ray Wen 《Journal of biomolecular structure & dynamics》2013,31(12):1358-1369
Overexpression of epidermal growth factor receptor (EGFR), Her2, and uroporphyrinogen decarboxylase (UROD) occurs in a variety of malignant tumor tissues. UROD has potential to modulate tumor response of radiotherapy for head and neck cancer, and EGFR and Her2 are common drug targets for the treatment of head and neck cancer. This study attempts to find a possible lead compound backbone from TCM Database@Taiwan (http://tcm.cmu.edu.tw/) for EGFR, Her2, and UROD proteins against head and neck cancer using computational techniques. Possible traditional Chinese medicine (TCM) lead compounds had potential binding affinities with EGFR, Her2, and UROD proteins. The candidates formed stable interactions with residues Arg803, Thr854 in EGFR, residues Thr862, Asp863 in Her2 protein, and residues Arg37, Arg41 in UROD protein, which are key residues in the binding or catalytic domain of EGFR, Her2, and UROD proteins. Thus, the TCM candidates indicated a possible molecule backbone for evolving potential inhibitors for three drug target proteins against head and neck cancer.An animated interactive 3D complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:35 相似文献
824.
825.
826.
Zhao X. Chen L. Ren Q. Wu Z. Fang S. Jiang Y. Chen Y. Zhong Y. Wang D. Wu J. Zhang G. 《Applied Biochemistry and Microbiology》2021,57(3):344-350
Applied Biochemistry and Microbiology - A pyridine-transforming strain P2 was isolated from sewage collected from Guangzhou oil stain field(China).According to the system analysis, it was... 相似文献
827.
Dong Chengya Wen Shaohong Zhao Shunying Sun Si Zhao Shangfeng Dong Wen Han Pingxin Chen Qingfang Gong Ting Chen Wentao Liu Wenqian Liu Xiangrong 《Neurochemical research》2021,46(4):755-769
Neurochemical Research - Cerebral ischemia leads to reactive astrogliosis and glial scar formation. Glial scarring can impede functional restoration during the recovery phase of stroke. Salidroside... 相似文献
828.
829.
Yexin Wang Xuzhuo Chen Xinwei Chen Zhihang Zhou Weifeng Xu Feng Xu Shanyong Zhang 《Journal of cellular physiology》2019,234(7):10432-10444
Chronic periodontitis (CP) is one of the most common oral diseases, which is characterized by the loss of connective tissue and alveolar bone in adults. AZD8835, a novel dual phosphoinositide-3-kinase (PI3K) inhibitor, is currently in phase 1 clinical evaluation to treat breast cancer. However, whether AZD8835 has any effect on teeth and alveolar bone health remains unclear. In the current study, we aimed to investigate the potential effect of AZD8835 in treating CP in vitro and in vivo. We found that AZD8835 could inhibit osteoclast differentiation, bone resorption, and downregulate the expression of osteoclast marker genes, such as tartrate-resistant acid phosphatase (Trap), cathepsin K (Ctsk), V-ATPase d2 (Atp6v0d2), and calcitonin receptor (Ctr). In addition, AZD8835 suppressed osteoclastogenesis by inhibiting receptor activator of nuclear factor kappa B ligand (RANKL)-induced PI3K/protein kinase B (AKT), extracellular signal-regulated kinase, and nuclear factor-κB signaling in BMMs. In vivo, AZD8835 greatly ameliorated alveolar bone (ABL) loss in rats with CP. Meanwhile, histological examination showed fewer osteoclasts in the treatment group. In conclusion, these results indicated that AZD8835 is a promising agent to reduce ABL in CP. 相似文献
830.
Ye Jin Yang Liu Lei Zhao Fuya Zhao Jing Feng Shengda Li Huinan Chen Jiayu Sun Biqiang Zhu Rui Geng Yunwei Wei 《Environmental microbiology》2019,21(2):772-783
Colorectal cancer (CRC) is a common disease worldwide that is strongly associated with the gut microbiota. However, little is known regarding the gut microbiota after surgical treatment. 16S rRNA gene sequencing was used to evaluate differences in gut microbiota among colorectal adenoma patients, CRC patients, CRC postoperative patients and healthy controls by comparing gut microbiota diversity, overall composition and taxonomic signature abundance. The gut microbiota of CRC patients, adenoma patients and healthy controls developed in accordance with the adenoma-carcinoma sequence, with impressive shifts in the gut microbiota before or during the development of CRC. The gut microbiota of postoperative patients and CRC patients differed significantly. Subdividing CRC postoperative patients according to the presence or absence of newly developed adenoma which based on the colonoscopy findings revealed that the gut microbiota of newly developed adenoma patients differed significantly from that of clean intestine patients and was more similar to the gut microbiota of carcinoma patients than to the gut microbiota of healthy controls. The alterations of the gut microbiota between the two groups of postoperative patients corresponded to CRC prognosis. More importantly, we used the different gut microbiota as biomarkers to distinguish postoperative patients with or without newly developed adenoma, achieving an AUC value of 0.72. These insights on the changes in the gut microbiota of CRC patients after surgical treatment may allow the use of the microbiota as non-invasive biomarkers for the diagnosis of newly developed adenomas and to help prevent cancer recurrence in postoperative patients. 相似文献